Biosimilars Market Analysis and Economics

Biosimilars Market Analysis and Economics Photo
The U.S. takes the lion's offer (49 percent) of the worldwide biologics showcase esteem and creates half of the business esteem development also. The EU represents 22 percent of the market's business esteem and 14 percent of its esteem development. Conversely, developing markets speak to only a fragment of the business pie, with 7.5 percent share. Accordingly, biologics showcase development is still generally determined by develop markets. The worldwide biologics advertise had come to $170 billion in deals an incentive in 2012, representing 18 percent of the general market. The five best 10 worldwide items regarding deals volume are biologics, wherein 2008 it was only two. The market in the APAC district for biosimilars came to $605 million out of 2010 and $683 million out of 2011. The market is required to reach $1.1 billion by 2016, a CAGR of 10.3%. The market in the United States for biosimilars came to $507 million out of 2010 and $1.1 billion out of 2011. The market is relied upon to reach $1.3 billion by 2016, a CAGR of 4.1%.
  • Pharmacoeconomic Modelling of Biosimilars
  • Risk management plan (RMP) for Biosimilars
  • Return on Investment for Biosimilars
  • Biosimilars China and Asia Pacific
  • Biosimilars India
  • Biosimilars USA
  • Biosimilars Europe
  • Economic aspect towards Biosimilars

Are you interested in

Mail us at

Programs & Speaking Engagement
Group Discounts and Delegates
More details about

Authorization Policy

By registering for the conference you grant permission to Allied Academies to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute,broadcast,edit and/or digitize the resulting images and materials in publications, advertising materials,or in any other form worldwide without compensation. Taking of photographs and/or video taping during any session is prohibited. Contact us for any queries
Copyright © 2017-2018 Allied Academies, All Rights Reserved.